Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer
| Status: | Completed |
|---|---|
| Conditions: | Ovarian Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 9/30/2017 |
| Start Date: | April 11, 2014 |
| End Date: | September 26, 2017 |
Feasibility and Preliminary Outcomes of Survivorship Care Planning in Ovarian Cancer
This pilot clinical trial studies survivorship care planning in supporting quality of life in
ovarian cancer survivors following primary treatment. Survivorship care plans have the
potential to empower patients and provide them with a plan of care following treatments.
Survivorship care planning may support patient's overall well-being and quality of life after
treatment of ovarian cancer.
ovarian cancer survivors following primary treatment. Survivorship care plans have the
potential to empower patients and provide them with a plan of care following treatments.
Survivorship care planning may support patient's overall well-being and quality of life after
treatment of ovarian cancer.
PRIMARY OBJECTIVES:
I. To assess the feasibility and acceptability of survivorship care planning (SCP) in ovarian
cancer.
SECONDARY OBJECTIVES:
I. To develop the infrastructure and strategy for a larger comparative intervention study
(National Cancer Institute [NCI] R01).
OUTLINE: Participants are assigned to 1 of 2 arms.
ARM I: Participants receive standard post-treatment care consisting of regular cancer
surveillance visits with treating oncologists.
ARM II: Participants complete survivorship care planning in close collaboration with treating
oncologists.
After completion of study treatment, participants are followed up at 2 months.
I. To assess the feasibility and acceptability of survivorship care planning (SCP) in ovarian
cancer.
SECONDARY OBJECTIVES:
I. To develop the infrastructure and strategy for a larger comparative intervention study
(National Cancer Institute [NCI] R01).
OUTLINE: Participants are assigned to 1 of 2 arms.
ARM I: Participants receive standard post-treatment care consisting of regular cancer
surveillance visits with treating oncologists.
ARM II: Participants complete survivorship care planning in close collaboration with treating
oncologists.
After completion of study treatment, participants are followed up at 2 months.
Inclusion Criteria:
- Diagnosis of stage I, II, or III ovarian cancer
- Ability to read or understand English
- All subjects must have the ability to understand and the willingness to sign a written
informed consent
Exclusion Criteria:
- Subjects, who in the opinion of the investigator, may not be able to comply with the
safety monitoring requirements of the study
We found this trial at
1
site
Click here to add this to my saved trials
